Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
Active, not recruiting · NCT05673083 · Registry updated 2025-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Not stated | 2025-09-04 | NCT05673083 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| All4Cure | 3 |
| GlaxoSmithKline | 294 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Specialists of North Florida | Jacksonville | United States | 1 |
| Hematology-Oncology Associates of Central New York | East Syracuse | United States | 1 |
| Highlands Oncology Group | Fayetteville | United States | 16 |
| Misson Cancer + Blood | Des Moines | United States | 1 |
| Northwest Medical Specialties PLLC | Tacoma | United States | 97 |
| Oklahoma Cancer Specialists and Research Institute | Tulsa | United States | 7 |
| Oncology Consultants | Houston | United States | 22 |